News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
11 08 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that MyQuest, used by more than six million people to see, store and share...
11 08 2018 - Quest to participate as in-network provider of laboratory services for Horizon Blue Cross Blue Shield of New Jersey plan participantsHorizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) announced today that it is expanding its laboratory network by adding Quest Diagnostics (NYSE: DGX) as an in-network provider of...
11 07 2018 QuestDirect Builds on Quest's existing consumer offerings available through the new and improved MyQuest patient platform that lets people access their lab results, schedule appointments and pay billsQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced the launch of QuestDirect, an enhanced consumer-initiated testing service...
-
11 06 2018 Oxford Immunotec's T-SPOT®.TB Tuberculosis and Accutix™ Tick-Borne Disease Testing Services are Part of Quest Diagnostics' Portfolio of Innovative Infectious Disease Diagnostics Tests, Broadening Access in the United StatesQuest Diagnostics (NYSE: DGX) and Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that Quest Diagnostics has completed its previously announced acquisition of the U.S. laboratory...
-
11 01 2018 Relationship ensures broad access to innovative FIT test in the U.S.Bridgewater, N.J., and Secaucus, N.J., Nov 1, 2018 – Clinical Genomics, a leading innovator of tests for colorectal cancer, and Quest Diagnostics (NYSE: DGX), the world's leading provider of...
-
10 25 2018 Quest to Acquire the Outreach Laboratory Service Operations of Marin General HospitalQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Marin General Hospital, a not-for-profit, full-service hospital, have entered into a definitive...
-
10 23 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on...
-
10 23 2018 -- Third quarter revenues of $1.89 billion, up 1.8% from 2017Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2018 and...
-
10 22 2018 Relationship to expand access to quality, high value and innovative services for people in Flint and surrounding communitiesQuest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of the outreach laboratory services operation of...
-
10 16 2018 Four Presentations Reveal Genetic Insights from Quest's Advanced DiagnosticsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of four studies at the 2018 American Society of Human...